First Time Loading...

Inhibrx Inc
NASDAQ:INBX

Watchlist Manager
Inhibrx Inc Logo
Inhibrx Inc
NASDAQ:INBX
Watchlist
Price: 16.65 USD 2.52% Market Closed
Updated: Jun 10, 2024

Inhibrx Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inhibrx Inc
Change in Working Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Inhibrx Inc
NASDAQ:INBX
Change in Working Capital
$15.3m
CAGR 3-Years
7%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Change in Working Capital
$3.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
38%
Gilead Sciences Inc
NASDAQ:GILD
Change in Working Capital
-$2.2B
CAGR 3-Years
-33%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Amgen Inc
NASDAQ:AMGN
Change in Working Capital
-$422m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Change in Working Capital
-$275.3m
CAGR 3-Years
-158%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Change in Working Capital
$105.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Inhibrx Inc's Change in Working Capital?
Change in Working Capital
15.3m USD

Based on the financial report for Dec 31, 2023, Inhibrx Inc's Change in Working Capital amounts to 15.3m USD.

What is Inhibrx Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
29%

Over the last year, the Change in Working Capital growth was 386%. The average annual Change in Working Capital growth rates for Inhibrx Inc have been 7% over the past three years , 29% over the past five years .